There is a article
that would suggest that generic company’s products are not held to the same liability standards as the brand name product.
So the insurance industry is mandating generics both as generic substitution, therapeutic interchange and step therapy… to the point that some 75%-85% generic utilization is common place.
Is this the same industry – INSURANCE INDUSTRY – that benefits from not having to pay claims for claims against generic manufacturers?
Filed under: General dumb-ass problems
Leave a Reply